Mycoplasma - There might have been misunderstood, misdiagnosed, mistreated or over looked. Healing Lyme Disease Coinfections: Complementary and Holistic Treatments for Bartonella and Mycoplasma Each year Harvard researchers estimate there are nearly 250,000 new Lyme disease infections--only 10 percent of which will be accurately diagnosed. One of the largest factors in misdiagnosis of Lyme is the presence of other tick-borne infections, which mask or aggravate the symptoms of Lyme disease as well as complicate treatment. Two of the most common and damaging Lyme coinfections are Bartonella and Mycoplasma. Nearly 35 million people in the United States are asymptomatically infected with each of these pathogens, and at least 10 percent will become symptomatic every year--with symptoms ranging from arthritis to severe brain dysfunction. Distilling hundreds of peer-reviewed journal articles on the latest scientific research on Bartonella, Mycoplasma, and Lyme disease, Stephen Buhner examines the complex synergy between these infections and reveals how all three can go undiagnosed or resurface after antibiotic treatment. It is critically important to know the real cause as early as possible, and able to follow the chage of infectious state. This is one of the critical point where we have to think about the possibiloty of Mycoplasma Infcetious Diseases Mycoplasma Infectious Diseases is oftenly misunderstand as virus, because mycoplasma is smallest bacteria and behaves like virus. Mycoplasma Infectious Diseases is basically systemic vasculitis/neuritis. Mycoplasma Infectious Diseases is not only a cause of pneumonia but also asthma, arthritis, nephritis, meningitis, encephalitis, dermatitis, pancreatitis, hepatitis, abnormalities in blood, so on. The concept of “Mycoplasma Infectious Diseases” is broad from acute to chronic phase with a variegated condition. Therefore, it is confusing and difficult to identify the mycoplasma-infected patient among those of incurable diseases, such as autoimmune diseases, a rheumatic disease, a nervous system disorder, and hematological disorders. Regrettably, conventional diagnostic system has been helpful only for pneumonia, although it is critical turning point to find variegated Mycoplasma Infectious Diseases at an early stage for performing an effective medical protocol. Then, there was a problem to detect mycoplamsa by PCR. Because chronic Mycoplasma Infectiou Diseases is a whole body diseases based on vesculitis/neuritis, therefore, one specimin from blood or others does not reflect the state of infection quantitatively. Especially, there oftenly false negaive, even there are mycoplasmas could not detect it. From this reason, serum spcecific antibody titers are reliable marker for chronic infectious diseases. Fortunately, the cutting-edge technology based on the mycoplasma species-specific glycolipid-antigens, has made it possible to measure the amount of specific antibodies. The new technology provides a reliable marker to follow the state of Mycoplasma Infectious Diseases, monitoring the fluctuations of antibody titers. The cutting-edge technology has made it possible to measure the specific antibodies. The new diagnostics for “Mycoplasma Infectious Diseases” make it possible to monitor by measuring tiny fluctuations of antibody titers from zero. The new measuring methods, IgM, IgG, and IgA antibody amonts, using the mycoplasma species-specific glycolipid-antigens, are already established. ・Anti-Mycoplasma pneumonie-specific lipid-antigen IgM antibodies ・Anti-Mycoplasma pneumonie-specific lipid-antigen IgG antibodies ・Anti-Mycoplasma pneumonie-specific lipid-antigen IgA antibodies ・Anti-Mycoplasma fermentans-specific lipid-antigen IgM antibodies ・Anti-Mycoplasma fermentans-specific lipid-antigen IgG antibodies ・Anti-Mycoplasma fermentans-specific lipid-antigen IgA antibodies The new measuring method, IgM, IgG, and IgA antibody value is already possible. The measurement request of a sample becomes possible through clinic, hospital or medical institutions to the biggest clinical special reference laboratory. If we come to know the real cause of the illness, there is the way to remove the cause and cure it. In the case of mycoplasma it is possible. We start personalized/advanced medicine using the next generation diagnostics and concept based on the cutting edge technology.
Posted on: Sun, 05 Oct 2014 02:44:54 +0000
Trending Topics
Recently Viewed Topics
© 2015